127 related articles for article (PubMed ID: 16607958)
1. [Preparation of recombinant HIV-TATm-survivin (T34A) protein and its pro-apoptosis activity to cancer cells in vitro].
Zheng WY; Ma XY; Wei DZ; Wang JZ; Liu QH; Ma YS; Yang SL
Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):285-92. PubMed ID: 16607958
[TBL] [Abstract][Full Text] [Related]
2. High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro.
Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
J Biotechnol; 2006 May; 123(3):367-78. PubMed ID: 16406157
[TBL] [Abstract][Full Text] [Related]
3. Construction, expression, and purification of HIV-TAT-survivin (T34A) mutant: a pro-apoptosis protein in Escherichia coli.
Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
Protein Expr Purif; 2006 May; 47(1):36-44. PubMed ID: 16260148
[TBL] [Abstract][Full Text] [Related]
4. Effect on apoptosis and cell cycle of recombinant double negative dominant mutation Survivin (T34/117A) in breast cancer cell B-Cap-37.
Wang L; Kang Y; Zheng W; Li L; Shi L; Ma X
Biomed Pharmacother; 2014 Apr; 68(3):277-84. PubMed ID: 24513056
[TBL] [Abstract][Full Text] [Related]
5. Cloning, expression, and purification of the recombinant pro-apoptotic dominant-negative survivin T34A-C84A protein in Escherichia coli.
Tsai SL; Chang YC; Sarvagalla S; Wang S; Coumar MS; Cheung CHA
Protein Expr Purif; 2019 Aug; 160():73-83. PubMed ID: 31004782
[TBL] [Abstract][Full Text] [Related]
6. Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene.
Luo L; Du T; Zhang J; Zhao W; Cheng H; Yang Y; Wu Y; Wang C; Men K; Gou M
Int J Nanomedicine; 2016; 11():501-12. PubMed ID: 26893558
[TBL] [Abstract][Full Text] [Related]
7. Expression and purification of TAT-NDRG2 recombinant protein and evaluation of its anti-proliferative effect on LNCaP cell line.
Farokhinejad F; Behbahani AB; Rafiei Dehbidi GR; Takhshid MA
Protein Expr Purif; 2017 Oct; 138():25-33. PubMed ID: 28711733
[TBL] [Abstract][Full Text] [Related]
8. Pro-apoptosis and anti-proliferation effects of a recombinant dominant-negative survivin-T34A in human cancer cells.
Shen C; Liu W; Buck AK; Reske SN
Anticancer Res; 2009 Apr; 29(4):1423-8. PubMed ID: 19414397
[TBL] [Abstract][Full Text] [Related]
9. [Anti-prostate cancer activity of Survivin-T34A mutant in vitro and in vivo].
Pan L; Peng XC; Yuan QZ; Leng F; Yu DD; Shan Y; Li ZY; Wang CT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):390-3. PubMed ID: 20629305
[TBL] [Abstract][Full Text] [Related]
10. Genetic protein TmSm(T34A) enhances sensitivity of chemotherapy to breast cancer cell lines as a synergistic drug to doxorubicin.
Xu Y; Zheng W; Wang T; Wang P; Zhu L; Ma X
Biomed Pharmacother; 2012 Jul; 66(5):368-72. PubMed ID: 22560635
[TBL] [Abstract][Full Text] [Related]
11. [Prokaryotic expression, purification and antigenicity identification of recombinant human survivin protein].
Yin X; Wang W; Tian R; Xu Y; Yan J; Zhang W; Gao J; Yu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):877-81. PubMed ID: 23948420
[TBL] [Abstract][Full Text] [Related]
12. Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable Survivin antagonist.
Yan H; Thomas J; Liu T; Raj D; London N; Tandeski T; Leachman SA; Lee RM; Grossman D
Oncogene; 2006 Nov; 25(52):6968-74. PubMed ID: 16702945
[TBL] [Abstract][Full Text] [Related]
13. A recombinant protein TmSm(T34A) can inhibit proliferation and proapoptosis to breast cancer stem cells(BCSCs) by down-regulating the expression of Cyclin D1.
Ma X; Zhang Y; Kang Y; Li L; Zheng W
Biomed Pharmacother; 2016 Dec; 84():373-381. PubMed ID: 27668537
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human Tat-Hsp70-2: A tool for neuroprotection.
Cappelletti P; Binda E; Tunesi M; Albani D; Giordano C; Molla G; Pollegioni L
Protein Expr Purif; 2017 Oct; 138():18-24. PubMed ID: 27405095
[TBL] [Abstract][Full Text] [Related]
15. HIV-TAT-fused FHIT protein functions as a potential pro-apoptotic molecule in hepatocellular carcinoma cells.
Yu GR; Qin WW; Li JP; Hua W; Meng YL; Chen R; Yan B; Wang L; Zhang X; Jia LT; Zhao J; Zhang R; Yang AG
Biosci Rep; 2012 Jun; 32(3):271-9. PubMed ID: 21679157
[TBL] [Abstract][Full Text] [Related]
16. [The fusion construction of HIV-1 Tat gene and efficient expression in E.coli].
Lin JP; Wang H; Wang L; Wei HF; Hu XP; Wang LY; Yu YL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):33-6. PubMed ID: 15629079
[TBL] [Abstract][Full Text] [Related]
17. [Effects of Survivin-T34A mutant on breast cancer cell in vitro and in vivo].
Deng X; Song H; Ren M
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Jun; 31(3):648-51. PubMed ID: 25219251
[TBL] [Abstract][Full Text] [Related]
18. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.
Peng XC; Yang L; Yang LP; Mao YQ; Yang HS; Liu JY; Zhang DM; Chen LJ; Wei YQ
J Exp Clin Cancer Res; 2008 Sep; 27(1):46. PubMed ID: 18816410
[TBL] [Abstract][Full Text] [Related]
19. [Cloning, expression and identification of human survivin in E. coli].
Bie J; Sun MS; Sun QM; Zheng JP; Sun WJ
Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):913-6. PubMed ID: 15321760
[TBL] [Abstract][Full Text] [Related]
20. A novel method for promoting heterologous protein expression in Escherichia coli by fusion with the HIV-1 TAT core domain.
Wu Y; Ren C; Gao Y; Hou B; Chen T; Zhang C
Amino Acids; 2010 Aug; 39(3):811-20. PubMed ID: 20213440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
